LEMAITRE VASCULAR, INC. (LMAT) Total liabilities 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) total liabilities at each fiscal year-end, per SEC filings.
$222.2MFY2025 · since FY2016: $14.4M → $222.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $222.2M | +3.6% |
| FY2024 | $214.5M | +338.9% |
| FY2023 | $48.9M | +15.6% |
| FY2022 | $42.3M | +9.4% |
| FY2021 | $38.7M | -51.8% |
| FY2020 | $80.2M | +99.6% |
| FY2019 | $40.2M | +75.9% |
| FY2018 | $22.9M | +38.1% |
| FY2017 | $16.6M | +14.8% |
| FY2016 | $14.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice